| 000 | 01877 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515143805.0 | ||
| 264 | 0 | _c20081210 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1523-6536 | ||
| 024 | 7 |
_a10.1016/j.bbmt.2008.08.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKersting, Sabina | |
| 245 | 0 | 0 |
_aSuccessful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction. _h[electronic resource] |
| 260 |
_bBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _cNov 2008 |
||
| 300 |
_a1312-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xmortality |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Diseases _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 700 | 1 | _aVerdonck, Leo F | |
| 773 | 0 |
_tBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _gvol. 14 _gno. 11 _gp. 1312-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbmt.2008.08.015 _zAvailable from publisher's website |
| 999 |
_c18403762 _d18403762 |
||